Christopher T. Kirchmer was named to the Plaintiffs Leadership Counsel (PLC) for the Bard IVC filter litigation by Judge David G. Campbell on October 30, 2015. Kirchmer joins a select group of attorneys from across the country who were appointed to serve on the committee for the Multi-District Litigation (MDL).
In addition to being appointed to the PLC, Kirchmer has more than 300 IVC filter cases, and he is lead counsel in two Bard IVC filter cases that are in the advanced stages of trial preparation. Kirchmer is one of the few lawyers in the country who has litigated Bard IVC filter cases up to the brink of trial.
Kirchmer has practiced with Provost Umphrey for his entire 20 year career. For the past 11 years, he has focused exclusively on pharmaceutical and medical device litigation. He was named to the 2016 Best Lawyers in America list by US News & World Report for Product Liability Litigation - Plaintiffs.
This is the second Plaintiff's Steering Committee for Kirchmer. He was appointed to the PSC in the Hormone Replacement Therapy MDL. He has handled cases in more than 25 MDLs, including current MDLs for Testosterone replacement therapy, Xarelto, Actos, Stryker hip replacements, Transvaginal Mesh and Cook IVC filters in addition to the Bard IVC filter MDL.
Provost Umphrey is no stranger to leading in mass tort and complex litigation. The firm initiated and served as lead counsel in Cimino v. Raymark Industries, Inc., the first landmark consolidation of 2,298 asbestos cases
. The firm was also appointed Lead Counsel in the $17.3 billon Texas Tobacco Litigation by Texas Attorney General Dan Morales.